401.6 - Conventional chemoembolization and drug-eluting beads (ID: 44552)

R. C. Martin

Topic:

Oncology

Session:

EM 401 - ECIO meets ESMO: Current concepts in the treatment of colorectal hepatic metastases (6 presentations)

1400a.2 - DC Bead M1 managing metastatic disease. Clinical rational and pilot data. (ID: 47216)

R. C. Martin

Topic:

Oncologic intervention | Others

Session:

SY 1400a - Biocompatibles: DC Bead - setting the standard in interventional oncology (2 presentations)

2301.2 - International hepatic arterial embolisation registry for hepatocellular cancer: surgical Down staging (ID: 39512)

R. C. Martin

Topic:

Embolization

Session:

SY 2301 - Angiodynamics/Biocompatibles - The multimodality management of soft tissue tumors: RFA, embolization and irreversible electropor (2 presentations)

902.3 - Irreversible electroporation (IRE) in locally advanced pancreatic cancer: multi-institutional evaluation and planned initiation of Phase II clinical trials (ID: 127)

R. C. Martin

Session:

SY 902 - AngioDynamics: Clinical experience with irreversible electroporation (3 presentations)

401.5 - Is there a place for local chemotherapy to the liver? (ID: 20)

R. C. Martin

Session:

CF 401 - Controversies in the treatment of colorectal hepatic metastases (5 presentations)

1202.1 - Management of diffuse hepatocellular cancer (≥ 10 lesions) with doxorubicin-loaded DC bead is a safe and effective treatment option (ID: 46052)

R. C. Martin, I. Kralj, A. Valdata, J. Urbano, J. Palmero, D. Pérez Enguix, R. D. Garcia-Mónaco, C. Tatum

Topic:

Oncologic intervention

Session:

FP 1202 - Oncologic interventions 1: DC bead embolization (5 presentations)

1201.3 - Non-thermal ablation using irreversible electroporation (IRE): initial U.S. clinical experience (ID: 46361)

R. C. Martin

Topic:

Oncology

Session:

SY 1201 - AngioDynamics: Irreversible electroporation: the next frontier for focal ablative therapy. Early human experience at three centers (3 presentations)

1801.3 - Non-thermal ablation using irreversible electroporation (IRE): U.S. clinical experience (ID: 58113)

R. C. Martin

Topic:

Oncologic intervention | Others

Session:

SY 1801 - AngioDynamics: Irreversible electroporation: clinical experience, outcomes, and applications of this emerging focal ablation modality (3 presentations)

1202.5 - Optimal technique of doxorubicin DC bead in hepatocellular cancer: small bead vs large bead, one vial vs two vials, complete stasis vs partial stasis (ID: 46278)

R. C. Martin, J. Irurzun, J. Munchart, I. Trofimov, A. Scupchenko, L. Rustein, G. Narayanan

Topic:

Oncologic intervention

Session:

FP 1202 - Oncologic interventions 1: DC bead embolization (5 presentations)

700a.2 - TACE with DC Bead in atypical metastatic patients: data from 350 patient global registry (ID: 43802)

R. C. Martin

Session:

SY 700a - Biocompatibles: DC Bead in HCC transplant and atypical metastatic patients (2 presentations)